| scholarly article | Q13442814 |
| P50 | author | Jonas Frisén | Q5744982 |
| Hjalmar Brismar | Q37622018 | ||
| Oleg Shupliakov | Q42619599 | ||
| Marie Carlén | Q58764436 | ||
| Robert M. Cassidy | Q58764449 | ||
| P2093 | author name string | Ming Zhao | |
| Ann Marie Janson | |||
| Clas B Johansson | |||
| Kioumars Delfani | |||
| Stefan Momma | |||
| P2860 | cites work | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 |
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| Subventricular zone astrocytes are neural stem cells in the adult mammalian brain | Q28137965 | ||
| Prospects for new restorative and neuroprotective treatments in Parkinson's disease | Q28138668 | ||
| Induction of neurogenesis in the neocortex of adult mice | Q28139868 | ||
| Neurogenesis in the neocortex of adult primates | Q28145880 | ||
| Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors | Q28219372 | ||
| Neurogenesis in the adult human hippocampus | Q28288339 | ||
| Mammalian neural stem cells | Q29547657 | ||
| Neuronal replacement from endogenous precursors in the adult brain after stroke | Q29615772 | ||
| Functional neurogenesis in the adult hippocampus | Q29618708 | ||
| Get to know your stem cells | Q33840674 | ||
| Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. | Q33951456 | ||
| Identification of a neural stem cell in the adult mammalian central nervous system | Q34492720 | ||
| Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons | Q35765360 | ||
| Proliferation of subependymal cells in the adult primate CNS: differential uptake of DNA labelled precursors | Q36634332 | ||
| Stem cells in the central nervous system | Q41116811 | ||
| Selective hippocampal lesions differentially affect the phenotypic fate of transplanted neuronal precursor cells | Q41202831 | ||
| The adult substantia nigra contains progenitor cells with neurogenic potential. | Q44085183 | ||
| (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. | Q46234212 | ||
| Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP. | Q48245363 | ||
| Embryonic and postnatal injections of bromodeoxyuridine produce age-dependent morphological and behavioral abnormalities | Q48270294 | ||
| Dissociation of crossed and uncrossed nigrostriatal projections with respect to site of origin in the rat. | Q48371022 | ||
| Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. | Q48408339 | ||
| Lesion-induced proliferation of neuronal progenitors in the dentate gyrus of the adult rat. | Q48631431 | ||
| Functional integration of adult-born neurons. | Q48637283 | ||
| Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. | Q48671187 | ||
| Early postmitotic neurons transiently express TOAD-64, a neural specific protein. | Q51124542 | ||
| The efficiency of systematic sampling in stereology--reconsidered. | Q52213559 | ||
| From entropy to Duino | Q59093375 | ||
| Neural stem cells in the adult human brain | Q73236390 | ||
| Mitotically active cells that generate neurons and astrocytes are present in multiple regions of the adult mouse hippocampus | Q74039026 | ||
| Infection and spread of alphaherpesviruses in the nervous system | Q77802801 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurogenesis | Q1456827 |
| substantia nigra | Q753278 | ||
| P304 | page(s) | 7925-7930 | |
| P577 | publication date | 2003-06-05 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Evidence for neurogenesis in the adult mammalian substantia nigra | |
| P478 | volume | 100 |
| Q41428650 | A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats |
| Q39342788 | Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease. |
| Q37795968 | Adult Hippocampal Neurogenesis: A Possible Way how Physical Exercise Counteracts Stress |
| Q38552670 | Adult Neurogenesis 50 Years Later: Limits and Opportunities in Mammals |
| Q55190848 | Adult Neurogenesis in Injury-Induced Self-Repair: Use It or Lose It. |
| Q33881835 | Adult human neurogenesis: from microscopy to magnetic resonance imaging |
| Q37129803 | Adult neural stem cells: The promise of the future |
| Q36735341 | Adult neural stem cells: redefining the physio- and pathology of the CNS. |
| Q24678292 | Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells |
| Q36404122 | Adult neurogenesis and functional plasticity in neuronal circuits |
| Q36804595 | Adult neurogenesis and neurodegenerative disease |
| Q36164726 | Adult neurogenesis and the ischemic forebrain |
| Q38024276 | Adult neurogenesis in Parkinson's disease |
| Q37935081 | Adult neurogenesis in mammals--a theme with many variations. |
| Q38027842 | Adult neurogenesis in the central and peripheral nervous systems. |
| Q37083653 | Adult neurogenesis pharmacology in neurological diseases and disorders |
| Q28284530 | Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells |
| Q33634893 | Adult neuroplasticity: more than 40 years of research |
| Q35673878 | Advances toward regenerative medicine in the central nervous system: challenges in making stem cell therapy a viable clinical strategy |
| Q37735812 | Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta. |
| Q48469356 | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
| Q34033021 | Allopregnanolone and neurogenesis in the nigrostriatal tract |
| Q35947523 | Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease |
| Q27334826 | Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease |
| Q96823591 | Allopregnanolone restores the tyrosine hydroxylase-positive neurons and motor performance in a 6-OHDA-injected mouse model |
| Q42812872 | Analysis of adenovirus gene transfer into adult neural stem cells |
| Q34513208 | Androgen decreases dopamine neurone survival in rat midbrain |
| Q34072691 | Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus |
| Q36003816 | Brain plasticity and antidepressant treatments: new cells, new connections |
| Q31146895 | Brain repair by cell replacement and regeneration |
| Q36488721 | Brain tumour stem cells |
| Q89930608 | Brainstem volume mediates seasonal variation in depressive symptoms: A cross sectional study in the UK Biobank cohort |
| Q36130681 | Can endocrine disruptors influence neuroplasticity in the aging brain? |
| Q35917764 | Can endogenous stem cells be stimulated to repair the degenerating brain? |
| Q36985844 | Cell proliferation and survival in the mating circuit of adult male hamsters: effects of testosterone and sexual behavior |
| Q37732186 | Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives |
| Q36883772 | Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease. |
| Q48335615 | Cells expressing markers of immature neurons in the amygdala of adult humans |
| Q48460391 | Cellular composition and cytoarchitecture of the rabbit subventricular zone and its extensions in the forebrain |
| Q48570342 | Central Nervous System and Vertebrae Development in Horses: a Chronological Study with Differential Temporal Expression of Nestin and GFAP. |
| Q37981219 | Characteristic features of stem cells in glioblastomas: from cellular biology to genetics |
| Q41812452 | Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture |
| Q46639055 | Characterization of neural stem cells on electrospun poly(epsilon-caprolactone) submicron scaffolds: evaluating their potential in neural tissue engineering |
| Q37229762 | Circumventricular organs: a novel site of neural stem cells in the adult brain |
| Q40546903 | Comparison of embryonic stem cell-derived dopamine neuron grafts and fetal ventral mesencephalic tissue grafts: morphology and function |
| Q36041764 | Constitutive and induced neurogenesis in the adult mammalian brain: manipulation of endogenous precursors toward CNS repair |
| Q26751456 | Control of adult neurogenesis by programmed cell death in the mammalian brain |
| Q38195546 | Current perspectives on the link between neuroinflammation and neurogenesis |
| Q36847262 | Death in the substantia nigra: a motor tragedy |
| Q46517248 | Development of A9/A10 dopamine neurons during the second and third trimesters in the African green monkey |
| Q36080085 | Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans |
| Q34684014 | Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration. |
| Q38155414 | Disruption of neurogenesis by hypothalamic inflammation in obesity or aging |
| Q48478186 | Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior. |
| Q36953951 | Dopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing Progenitors |
| Q36652288 | Dopamine and adult neurogenesis |
| Q34326801 | Dopamine depletion impairs precursor cell proliferation in Parkinson disease. |
| Q46549241 | Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. |
| Q46792157 | Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration. |
| Q36012093 | Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease |
| Q41857057 | Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation |
| Q37654778 | Emerging roles of Wnts in the adult nervous system |
| Q35730391 | Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice |
| Q37403681 | Environmental and behavioral modulation of the number of substantia nigra dopamine neurons in adult mice |
| Q28468524 | Environmental modulations of the number of midbrain dopamine neurons in adult mice |
| Q53528240 | Evidence for constitutive neural cell proliferation in the adult murine hypothalamus. |
| Q48153817 | Evidence for newly generated interneurons in the basolateral amygdala of adult mice |
| Q38338153 | Evidence for the spontaneous production but massive programmed cell death of new neurons in the subcallosal zone of the postnatal mouse brain |
| Q92680583 | Exosomal 2',3'-CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis/neuritogenesis and contributes to rescue of cognition/learning deficiencies of damaged brain |
| Q43972000 | Exposure of foetal neural progenitor cells to IL-1β impairs their proliferation and alters their differentiation - a role for maternal inflammation? |
| Q34212651 | FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease |
| Q33829887 | Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease |
| Q36342360 | From angiogenesis to neuropathology |
| Q38100616 | Functional implications of hippocampal adult neurogenesis in intellectual disabilities |
| Q36105469 | G-protein-coupled receptors in adult neurogenesis |
| Q33281118 | Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisation |
| Q36003798 | Gene-environment interplay in neurogenesis and neurodegeneration |
| Q48485136 | Genetic visualization of neurogenesis |
| Q100535719 | Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives |
| Q38203839 | Harnessing neurogenesis for the possible treatment of Parkinson's disease |
| Q34100703 | Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia |
| Q51916614 | How useful are stem cells in PD therapy? |
| Q36827189 | How widespread is adult neurogenesis in mammals? |
| Q57837849 | Human Wild-Type α-Synuclein Impairs Neurogenesis |
| Q38107692 | Hypothalamic neurogenesis in the adult brain |
| Q37885785 | Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus |
| Q34158254 | Immunological control of adult neural stem cells |
| Q82587964 | Increased BrdU incorporation reflecting DNA repair, neuronal de-differentiation or possible neurogenesis in the adult cochlear nucleus following bilateral cochlear lesions in the rat |
| Q58621525 | Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice |
| Q42816684 | Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl. |
| Q48629944 | Increased number of TH-immunoreactive cells in the ventral tegmental area after deep brain stimulation of the anterior nucleus of the thalamus |
| Q92364375 | Increasing Adiponergic System Activity as a Potential Treatment for Depressive Disorders |
| Q44884769 | Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation |
| Q29619040 | Inflammation is detrimental for neurogenesis in adult brain |
| Q37254517 | Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders |
| Q37806142 | Injury-induced neurogenesis in the mammalian forebrain |
| Q46847882 | Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats. |
| Q24654644 | Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons |
| Q47106162 | Involvement of GSK-3β Phosphorylation Through PI3-K/Akt in Cerebral Ischemia-Induced Neurogenesis in Rats. |
| Q96110286 | Ischemic Injury Does Not Stimulate Striatal Neuron Replacement Even during Periods of Active Striatal Neurogenesis |
| Q37968033 | M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models |
| Q42482127 | Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis |
| Q80610155 | Marked species and age-dependent differences in cell proliferation and neurogenesis in the hippocampus of wild-living rodents |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q40061010 | Methods of reactivation and reprogramming of neural stem cells for neural repair |
| Q28283415 | Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson's disease? |
| Q47931720 | Motherhood and infant contact regulate neuroplasticity in the serotonergic midbrain dorsal raphe |
| Q38952117 | Mouse embryonic stem cell-derived cells reveal niches that support neuronal differentiation in the adult rat brain |
| Q36641684 | Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. |
| Q36586431 | Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice |
| Q61311153 | Neural microvascular pericytes contribute to human adult neurogenesis |
| Q61804450 | Neural plasticity and adult neurogenesis: the deep biology perspective |
| Q26995185 | Neural stem cell niches in health and diseases |
| Q38268886 | Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression |
| Q35576478 | Neural stem cells: historical perspective and future prospects. |
| Q51790795 | Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. |
| Q37978305 | Neurogenesis in Neurotoxin-induced Animal Models for Parkinson's Disease-A Review of the Current Status |
| Q37735817 | Neurogenesis in substantia nigra of parkinsonian brains? |
| Q37621803 | Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice |
| Q38368567 | Neurogenesis within the adult hippocampus under physiological conditions and in depression |
| Q36334459 | Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice |
| Q36707992 | Neuroimmunopathology in a murine model of neuropsychiatric lupus |
| Q48304089 | Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons. |
| Q40597127 | Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D3 Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra |
| Q36687848 | Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease |
| Q35681491 | Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration |
| Q42118272 | Neuroscience. Is more neurogenesis always better? |
| Q47162932 | Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion |
| Q91637219 | New Neurons in the Post-ischemic and Injured Brain: Migrating or Resident? |
| Q36309558 | New neurons in old brains |
| Q51485827 | Newborn GnRH neurons in the adult forebrain of the ring dove. |
| Q47099458 | Nigral dopaminergic neuron replenishment in adult mice through VE-cadherin-expressing neural progenitor cells |
| Q30763914 | No evidence for new dopaminergic neurons in the adult mammalian substantia nigra |
| Q64118999 | Non-engineered and Engineered Adult Neurogenesis in Mammalian Brains |
| Q38589155 | Noncanonical Sites of Adult Neurogenesis in the Mammalian Brain |
| Q39155818 | Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice |
| Q91583400 | P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson's Disease |
| Q44817619 | PACAP promotes neural stem cell proliferation in adult mouse brain |
| Q34851255 | PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. |
| Q24537325 | Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice |
| Q40867948 | Peroral administration of 5-bromo-2-deoxyuridine in drinking water is not a reliable method for labeling proliferating S-phase cells in rats. |
| Q36071069 | Pharmacology of Alzheimer's disease: appraisal and prospects |
| Q35665339 | Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats. |
| Q34461436 | Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner |
| Q55420491 | Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease. |
| Q37014278 | Physiological, pathological, and engineered cell identity reprogramming in the central nervous system |
| Q43092577 | Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease |
| Q43198086 | Potential cellular and regenerative approaches for the treatment of Parkinson's disease. |
| Q37290610 | Potential of adult neural stem cells for cellular therapy. |
| Q37845409 | Programmed cell death during postnatal development of the rodent nervous system |
| Q28585790 | Programmed cell death of adult-generated hippocampal neurons is mediated by the proapoptotic gene Bax |
| Q24644384 | Proliferation, neurogenesis and regeneration in the non-mammalian vertebrate brain |
| Q36804536 | Protocols for studying adult neurogenesis: insights and recent developments |
| Q37034308 | Re-cycling paradigms: cell cycle regulation in adult hippocampal neurogenesis and implications for depression |
| Q30497049 | Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. |
| Q36687833 | Regenerating the brain |
| Q39699314 | Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain. |
| Q36261742 | Regulation and function of neurogenesis in the adult vertebrate brain |
| Q45927167 | Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. |
| Q37252748 | Role of phosphodiesterase 5 in synaptic plasticity and memory |
| Q37761846 | Seven kinds of intermediate filament networks in the cytoplasm of polarized cells: structure and function |
| Q27314710 | Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation |
| Q35213967 | Stem cell biology and neurodegenerative disease |
| Q35236822 | Stem cell therapy for Parkinson's disease. |
| Q35844778 | Stem cell therapy for human neurodegenerative disorders-how to make it work |
| Q41360983 | Stem cell transplantation for treating Parkinson's disease: Literature analysis based on the Web of Science |
| Q37857754 | Stem cell-based therapies in Parkinson's disease: future hope or current treatment option? |
| Q36309562 | Stem cell-based therapy for Parkinson's disease |
| Q37704372 | Stem cell-derived dopamine neurons for brain repair in Parkinson's disease |
| Q43089181 | Stem cells and cell replacement therapy for Parkinson's disease. |
| Q37453637 | Stem cells for enhancing recovery after stroke: a review. |
| Q34649735 | Stem-cell-based strategies for the treatment of Parkinson's disease |
| Q37902080 | Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cells |
| Q35553941 | TAM receptor deficiency affects adult hippocampal neurogenesis |
| Q41229573 | Targeting Adult Neurogenesis for Poststroke Therapy |
| Q41720010 | Targeting Cdk5 activity in neuronal degeneration and regeneration |
| Q38223428 | The (real) neurogenic/gliogenic potential of the postnatal and adult brain parenchyma |
| Q49265933 | The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis |
| Q36321051 | The cell cycle-apoptosis connection revisited in the adult brain |
| Q35781261 | The cellular repair of the brain in Parkinson's disease--past, present and future. |
| Q38242194 | The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging |
| Q36709957 | The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies |
| Q48013213 | The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflammation |
| Q38764948 | The neurosphere assay, a method under scrutiny |
| Q35652312 | The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease |
| Q36045389 | The repair of complex neuronal circuitry by transplanted and endogenous precursors |
| Q39257825 | Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice. |
| Q48518649 | Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease |
| Q37131248 | Therapeutic potentials of human embryonic stem cells in Parkinson's disease |
| Q38258250 | Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations |
| Q38950746 | Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis. |
| Q40202809 | Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. |
| Q37332898 | Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease |
| Q34328701 | Triple X syndrome: a review of the literature |
| Q38026794 | Tumor suppressive pathways in the control of neurogenesis. |
| Q33205365 | Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem |
| Q35867182 | Unconventional Neurogenic Niches and Neurogenesis Modulation by Vitamins |
| Q30479622 | Young thrombocytes initiate the formation of arterial thrombi in zebrafish |
| Q52286116 | [Adult brain neurogenesis and pathology] |
| Q50996441 | [Lifestyle and cognition: what do we know from the aging and neurodegenerative brain?]. |
| Q52286444 | [Neurogenesis. Relevance for pathophysiology and pharmacotherapy of psychiatric diseases]. |
| Q34223531 | p21Cip restrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation |
Search more.